Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 and up

Sucrosomial oral iron versus standard iron care after heart surgery

Official title: Pilot Study Evaluating Efficacy and Economic Advantage of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care in Patients After Cardiac Surgery

Run by Englewood Hospital and Medical Center · NCT06970925 · Data updated 2026-11-12

This trial will try sucrosomial oral iron to see if it raises hemoglobin as well as standard care in adults with iron deficiency or anemia after non-emergency heart surgery.

More Cardiac Surgery trials

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorEnglewood Hospital and Medical Center
Academic / other
Locations1 site (Englewood, New Jersey)
StatusRecruiting
StartedJune 30, 2025
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedOctober 27, 2026
Trial IDNCT06970925 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 who undergo non-emergent cardiac surgery and have postoperative iron deficiency or anemia (hemoglobin <12 g/dL) without excluded comorbidities are the intended participants.

Probably not a fit

Patients with very low hemoglobin on postoperative day 1 (<9 g/dL), age over 90, advanced renal disease (stage 3–4), active cancer or marrow disorders, or who received intraoperative transfusions are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional study compares post-operative sucrosomial oral iron with standard care (iron sucrose) in adults following non-emergent cardiac surgery. The primary aim is to show non-inferiority in hemoglobin improvement within 30 days after surgery. Secondary outcomes include treatment costs, transfusion requirements, and lengths of hospital and ICU stay. Eligible participants are adults with postoperative iron deficiency or anemia treated at Englewood Hospital in Englewood, New Jersey.

Why it matters

Potential benefit: If sucrosomial oral iron is non-inferior, patients could receive effective oral treatment that avoids IV iron, reduces costs, and may lower transfusion needs and hospital resource use.

How similar studies have gone: Oral sucrosomial iron has shown effectiveness for correcting iron deficiency in other settings, but direct evidence replacing IV iron after cardiac surgery is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ICU hospitalized patients who underwent non-emergent cardiac surgery
* Post operative iron deficient or anemic patients (Hb\< 12 for both men and women).
* Patients following the same pre-operative protocol
* Age \>18 years

Exclusion Criteria:

* Post operative day 1 and 2 Hg \<9
* Age \>90 years
* Patients with cancer or other chronic conditions that impair erythropoiesis (e.g. MDS)
* Stage 3, 4 renal disease
* Intraoperative transfusion of PRBC

Where it's running

  • Englewood Hospital
    Englewood, New Jersey, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.